Anthony Doyle - Dec 14, 2021 Form 4/A - Amendment Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
Chief Financial Officer
Signature
/s/ Alane P. Barnes, by power of attorney
Stock symbol
BCRX
Transactions as of
Dec 14, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
1/13/2022, 03:40 PM
Date Of Original Report
Dec 16, 2021
Previous filing
Nov 24, 2021
Next filing
Dec 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Award $0 +75K +80.03% $0.00 169K Dec 14, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of restricted stock units awarded to the reporting person on December 14, 2021 was overstated in the original Form 4 due to an administrative error. This amendment corrects the error and reflects the corrected amount of restricted stock units awarded to the reporting person on such date.